For instance, in triple-negative breast cancer (TNBC) models, SGLT1 expression significantly correlated with tumor size and clinical-pathological characteristics, presenting SGLT1 as a prognostic marker (Liu et al., 2019) and its SGLT1 overexpression correlates with worse outcomes in colorectal cancer patients (Guo et al., 2011). This evidence concerns the gene SLC5A1 and colorectal cancer.